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CD40 is a major regulator of dendrite
growth from developing excitatory and
inhibitory neurons
Paulina Carriba, Alun M Davies*
School of Biosciences, Cardiff University, Cardiff, United Kingdom
Abstract Dendrite size and morphology are key determinants of the functional properties of
neurons and neural circuits. Here we show that CD40, a member of the TNF receptor superfamily,
is a major regulator of dendrite growth and elaboration in the developing brain. The dendrites of
hippocampal excitatory neurons were markedly stunted in Cd40-/- mice, whereas those of striatal
inhibitory neurons were much more exuberant. These striking and opposite phenotypic changes
were also observed in excitatory and inhibitory neurons cultured from Cd40-/- mice and were
rescued by soluble CD40. The changes in excitatory and inhibitory neurons cultured from Cd40-/-
mice were mimicked in neurons of Cd40+/+ mice by treatment with soluble CD40L and were
dependent on PKC-b and PKC-g, respectively. These results suggest that CD40-activated CD40L
reverse signalling has striking and opposite effects on the growth and elaboration of dendrites
among major classes of brain neurons by PKC-dependent mechanisms.
DOI: https://doi.org/10.7554/eLife.30442.001
Introduction
The regulation of dendrite growth and elaboration during development has a major bearing on the
functional properties of neurons and neural circuits, and many neurodevelopmental and acquired
disorders of neural function are due primarily to structural abnormalities of dendrites and their con-
nections (Penzes et al., 2011). In addition to intrinsic developmental programmes and the pattern
of electrical activity, a wide variety of extrinsic signals orchestrate the growth and remodeling of
dendrites during development and maturation, including delta-notch, Eph-Ephrins, cell adhesion
molecules, neurotrophins, semaphorins and slits (Metzger, 2010; Valnegri et al., 2015). One of the
latest groups of proteins recognized to modulate growth of neural processes during development is
the tumor necrosis factor superfamily (TNFSF), the 19 members of which are best understood for
their many roles in the immune system (Hehlgans and Pfeffer, 2005). They are active both as mem-
brane-integrated ligands and as soluble ligands following cleavage from the cell membrane, and
bind to one or more members of the TNF receptor superfamily (TNFRSF). In addition, several
TNFRSF members can also function as ligands for membrane-integrated TNFSF binding partners
and initiate reverse signalling (Sun and Fink, 2007). Most of the work on the TNFSF and TNFRSF on
the regulation of neural process growth has focused on PNS neurons, where several members of
these superfamilies act on different kinds of neurons during circumscribed phases of development,
either enhancing or inhibiting axon growth (Desbarats et al., 2003; Gavalda` et al., 2009;
Gutierrez et al., 2013; Kisiswa et al., 2013, 2017; McWilliams et al., 2015; O’Keeffe et al., 2008;
Wheeler et al., 2014). In addition, several studies have implicated TNFSF members in regulating the
growth of neural processes in the developing CNS (Neumann et al., 2002; Oso´rio et al., 2014;
Zuliani et al., 2006; McWilliams et al., 2017).
We have investigated whether CD40 (TNFRSF5) plays a role in regulating the growth and elabora-
tion of dendrites in the developing CNS. CD40 and its ligand CD40L play key roles in immune
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responses and in the pathogenesis of autoimmune disease (Peters et al., 2009). CD40 and CD40L
have also recently been implicated in regulating sympathetic axon growth and are required for
establishing the innervation of particular tissues in the developing PNS (McWilliams et al., 2015).
Here, we focused on the two most extensively characterized populations of excitatory and inhibitory
projection neurons in the mouse brain, the excitatory glutamatergic pyramidal neurons of the hippo-
campus and the inhibitory GABA-ergic medium spiny neurons (MSNs) of the striatum. Hippocampal
pyramidal neurons are one of the best-characterized models for studying the differentiation and
growth of axons and dendrites during development (Kaech and Banker, 2006). MSNs comprise the
majority of neurons in the striatum, have extensive dendritic arbors, project to the surrounding nuclei
of the basal ganglia and their degeneration is the pathognomonic feature of Huntington’s disease
(Reiner et al., 1988). Both kinds of neurons are easily recognized by their distinctive morphologies
in vivo and can be cultured at a stage when they are elaborating dendrites and are the major cell
type in culture. Our demonstration that CD40-activated CD40L reverse signaling has pronounced
and distinctive effects on the growth and elaboration of dendrites from different classes of neurons
in vitro and in vivo has important implications for neural development and the establishment and
function of neural circuits.
Results
Phenotypic changes in the dendrites of excitatory and inhibitory
neurons of Cd40-/- mice
Golgi preparations carried out on Cd40+/+ and Cd40-/- mice at postnatal day 10 (P10) revealed that
the size and complexity of the dendritic arbors of hippocampal pyramidal neurons and striatal MSNs
were markedly affected in the absence of CD40, but in opposite ways. The dendritic arbors of the
excitatory pyramidal neurons of the CA fields of the hippocampus of Cd40-/- mice were dramatically
stunted compared with those of Cd40+/+ littermates (Figure 1A). Representative high power images
show that the reduction of dendrite size and complexity in Cd40-/- mice affected both apical and
basal dendrite compartments of these excitatory neurons (Figure 1B). Because the dendrite arbors
of pyramidal neurons in CA1 are normally less exuberant than those of other CA regions, CA1 pyra-
midal dendrites were especially amenable to analysis, which was carried out separately on the apical
and basal compartments. This revealed marked and highly significant reductions in total dendrite
length in both apical (p=6.0210 16) and basal (p=4.7510 14) compartments of Cd40-/- mice com-
pared with Cd40+/+ littermates (Figure 1C). These reductions were in reflected in the Sholl analyses
(Figure 1D), which plot branching in the dendrite arbors with distance from the cell body (two-way
ANOVA Cd40+/+ versus Cd40-/-, p=1.6710 14, apical dendrites and p=4.7510 5, basal den-
drites). Accordingly, quantification of the number of branch points in these dendrite compartments
showed clear statistically significant reductions in Cd40-/- mice (p=8.8510 7, apical and
p=6.4810 8, basal), however there was no significant difference (p=0.82) in the number of primary
dendrites between the pyramidal neurons of Cd40-/- and Cd40+/+ mice (Figure 1—figure supple-
ment 1). Taken together, these findings indicate that CD40 plays a major role in promoting the
growth and elaboration of hippocampal pyramidal neuron dendrites.
In marked contrast to hippocampal excitatory neurons, the dendritic arbors of the striatal MSNs
of Cd40-/- mice were very much larger and more profuse than those of Cd40+/+ littermates
(Figure 1E and F). Quantification of total dendrite length revealed a marked and highly significant
increase in Cd40-/- mice compared with Cd40+/+ littermates (p=6.8710 17) (Figure 1G). This
increase in dendrite size was in reflected in the Sholl analysis (Figure 1H) (two-way ANOVA Cd40+/+
versus Cd40-/-, p=6.6810 4). Quantification of the number of branch points in these dendrite com-
partments showed clear statistically significant increase in Cd40-/- mice (49% increase,
p=1.1310 13), and as with hippocampal pyramidal neurons, there was no significant difference in
the number of primary dendrites in the MSNs of Cd40-/- and Cd40+/+ mice (Figure 1—figure sup-
plement 1). These findings indicate that CD40 plays a major role in restricting the growth and elabo-
ration of MSN dendrites in the developing striatum.
To ascertain whether the striking phenotypic changes observed in the hippocampus and striatum
of early postnatal Cd40-/- mice are maintained in older mice, we compared Cd40-/- and Cd40+/+ lit-
termates in P30 and adult mice. Golgi preparations revealed that hippocampal pyramidal neuron
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Figure 1. Phenotypic changes in hippocampal pyramidal neurons and striatal MSNs in P10 Cd40-/- mice. (A) Representative low-power images of Golgi
preparations of the hippocampal CA regions and dentate gyrus of Cd40+/+ and Cd40-/- mice. Scale bar, 250 mm. (B) High-power images of CA1 and
CA3 pyramidal neurons of Cd40+/+ and Cd40-/- mice. Scale bar, 50 mm. (C) Quantification of the total apical dendrite lengths (Cd40+/+, n = 74 and
Cd40-/-, n = 67) and total basal dendrite lengths (Cd40+/+, n = 51 and Cd40-/-, n = 49) of CA1 pyramidal neurons of Cd40+/+ and Cd40-/- mice. (D) Sholl
plots of the apical (Cd40+/+, n = 86 and Cd40-/-, n = 71) and basal (Cd40+/+, n = 64 and Cd40-/-, n = 53) dendrites of CA1 pyramidal neurons. (E)
Representative low-power images of Golgi preparations of the striatum of Cd40+/+ and Cd40-/- mice. Scale bar, 250 mm. (F) Representative high-power
images of MSNs of Cd40+/+ and Cd40-/- mice. Scale bar, 20 mm. (G) Quantification of the total dendrite lengths of MSNs (Cd40+/+, n = 85 and Cd40-/-,
Figure 1 continued on next page
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dendrite arbors were clearly stunted in Cd40-/- mice compared with Cd40+/+ littermates whereas
striatal MSN dendrite arbors of Cd40-/- mice were much larger and more complex than those of
Cd40+/+ littermates both ages (Figure 1—figure supplement 2). This shows that the distinctive phe-
notypic changes evident in the dendrite arbors of both kinds neurons observed in the early postnatal
period are maintained throughout life.
Dendrite growth and elaboration is regulated by CD40-activated
CD40L reverse signalling
Interaction of CD40 and membrane-integrated CD40L can initiate bi-directional signaling: CD40L-
activated CD40-mediated forward signaling and CD40-activated CD40L-mediated reverse signaling
(Sun and Fink, 2007). To determine which signaling mechanism is responsible for the effects of
CD40 on dendrite growth and elaboration in hippocampal pyramidal neurons and striatal MSNs, we
established cultures of these neurons from Cd40-/- and Cd40+/+ mice and studied the effect of solu-
ble CD40L and soluble CD40.
Hippocampal pyramidal neuron cultures were established from E18 mice. By 9 days in vitro,
MAP-2-positive dendrites can be unambiguously identified and quantified (Kaech and Banker,
2006; Oso´rio et al., 2014). Similar to the phenotypic changes observed in Golgi preparations of
Cd40-/- mice, pyramidal neurons cultured from Cd40-/- mice were smaller than those cultured from
Cd40+/+ mice (Figure 2A). Measurement of the total dendrite length in the dendrite arbors of indi-
vidual neurons revealed a highly significant reduction in cultures established from Cd40-/- mice com-
pared with those cultured from Cd40+/+ mice (p=2.910 6) (Figure 2B), but no significant
difference in the number of primary dendrites (Figure 2—figure supplement 1). These data suggest
that the morphologies of hippocampal pyramidal neurons cultured from Cd40+/+ and Cd40-/- mice
reflect the phenotypic differences observed in vivo.
Treatment of pyramidal neurons cultured from Cd40+/+ mice with soluble CD40L significantly
reduced dendrite length to the same extent as that observed in untreated pyramidal neurons cul-
tured from Cd40-/- mice (p=1.110 8) (Figure 2B). Neither soluble CD40 (CD40-Fc chimera, in which
the extracellular domain of CD40 is linked to the Fc part of human IgG1) nor control Fc protein had
any significant effect on dendrite growth from pyramidal neurons cultured from Cd40+/+ mice. While
CD40L reduced dendrite growth from wild type neurons, it did not significantly affect dendrite
growth from pyramidal neurons of Cd40-/- mice (Figure 2B), suggesting that CD40L does not exert
a non-specific suppressive effect on dendrite growth. The most parsimonious explanation for these
results is that addition of CD40L to pyramidal neurons cultured from Cd40+/+ mice competes with
endogenous membrane integrated CD40L for binding to endogenous CD40, thereby blocking
CD40-activated CD40L-mediated reverse signalling. Further support for CD40-activated CD40L-
mediated reverse signaling came from phenotype rescue experiments. CD40-Fc, but not Fc control
protein, fully restored the reduced dendrite growth phenotype of pyramidal neurons cultured from
Cd40-/- mice (p=6.510 3) (Figure 2B). Taken together, these observations suggest that CD40-
Figure 1 continued
n = 89). (H) Sholl plots of MSN dendrites (Cd40+/+, n = 85 and Cd40-/-, n = 89). The means ± s.e.m are shown in C, D, G and H. Data were obtained
from neurons analysed in at least three mice of each genotype, ***p<0.0001 t-test (actual p values provided in the text). Sholl plots were analysed by
two-way ANOVA with Bonferroni post tests. The statistical significances for each distance from the soma are included in Figure 1—source data 3.
DOI: https://doi.org/10.7554/eLife.30442.002
The following source data and figure supplements are available for figure 1:
Source data 1. Data of individual Golgi-stained pyramidal neurons in Cd40+/+ and Cd40-/- mice.
DOI: https://doi.org/10.7554/eLife.30442.005
Source data 2. Data of individual Golgi-stained medium spiny neurons in Cd40+/+ and Cd40-/- mice.
DOI: https://doi.org/10.7554/eLife.30442.006
Source data 3. 2-way ANOVA for pyramidal neurons and medium spiny neurons in Cd40+/+ and Cd40-/- mice.
DOI: https://doi.org/10.7554/eLife.30442.007
Figure supplement 1. Opposite effects of the Cd40 null mutation on dendrite branching in hippocampal pyramidal neurons and striatal MSNs.
DOI: https://doi.org/10.7554/eLife.30442.003
Figure supplement 2. Phenotypic changes are maintained in P30 and adult Cd40-/- mice.
DOI: https://doi.org/10.7554/eLife.30442.004
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Figure 2. CD40-activated CD40L reverse signalling enhances dendrite growth from cultured hippocampal pyramidal neurons. (A) Representative
photomicrographs of hippocampal neurons of Cd40+/+ and Cd40-/- E18 embryos cultured for 9 days and treated 24 hr after plating with either soluble
CD40L (sCD40L), CD40-Fc or Fc protein (each at 1 mg/ml) or untreated (control). Scale bar, 100 mm. (B) Quantification of total dendrite lengths of
neurons in these cultures after 9 days in vitro. Mean ± s.e.m of data collected from three independent experiments from Cd40+/+ (control, n = 70;
Figure 2 continued on next page
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activated CD40L mediated reverse signalling promotes dendrite growth from developing hippocam-
pal pyramidal neurons.
In addition to dendrites, axons are clearly identifiable in cultures of developing hippocampal pyra-
midal neurons (Dotti et al., 1988; Kaech and Banker, 2006). Axons are the first processes to
emerge from the cell body and remain the longest process in longer-term cultures. This permitted
us to investigate the potential influence of CD40 signalling on pyramidal axon growth (Figure 3).
The axons of pyramidal neurons cultured from Cd40-/- mice were significantly shorter than the axons
of neurons cultured from Cd40+/+ mice in both 3 day and 9 day cultures (p=7.810 12, 3 days;
p=1.310 4, 9 days). The effects of CD40L and CD40-Fc on axon growth were very similar to the
effects of these reagents on dendrite growth. CD40L, but not CD40-Fc, suppressed axon growth
from Cd40+/+ neurons to the same extend as that observed in untreated Cd40-/- neurons
(p=6.410 11, 3 days; p=1.210 5, 9 days). The reduced axon growth phenotype of neurons of
Cd40-/- mice was completely rescued by CD40-Fc (p=2.610 5, 3 days; p=4.910 6, 9 days). These
results suggest that CD40-activated CD40L-mediated reverse signalling also enhances axon growth
from developing hippocampal pyramidal neurons in culture. However, because the full extent of
these axons cannot be reliably discerned in Golgi preparations, we cannot definitively conclude that
CD40L reverse signalling enhances the growth of pyramidal axons in vivo.
MSN cultures were established from E14 striatal primordia. Although MSNs comprise the vast
majority of neurons in the striatum, some contamination by adjoining regions is inevitable when dis-
secting striatal primordia from the E14 brain. For this reason, we positively identified MSNs using an
antibody to dopamine and cyclic AMP-regulated protein (DARPP-32), which is expressed by more
than 95% of MSNs (Ouimet et al., 1998). Similar to the phenotypic changes observed in Golgi prep-
arations of Cd40-/- mice, the neurite arbors of MSNs cultured from Cd40-/- mice were larger than
those of MSNs cultured from Cd40+/+ mice (Figure 4A). Although dendrites and axons cannot be
easily distinguished in these cultures, measurement of total neurite length confirmed highly signifi-
cant increases in neurons cultured from Cd40-/- mice compared with those cultured from Cd40+/+ lit-
termates (p=7.210 10) (Figure 4B). This suggests, as with hippocampal pyramidal neurons, that
the morphologies of MSNs cultured from Cd40+/+ and Cd40-/- mice reflect the phenotypic differen-
ces observed in vivo.
Treatment of MSNs cultured from Cd40+/+ mice with soluble CD40L caused a significant increase
in total neurite length (p=1.5710 6) that was similar to the total neurite length observed in
untreated MSNs cultured from Cd40-/- mice (Figure 4B). CD40-Fc did not affect neurite growth from
MSNs cultured from Cd40+/+ mice, but significantly reduced the more exuberant neurite growth of
MSNs cultured from Cd40-/- mice (p=3.610 14) to the level observed in untreated MSNs cultured
from Cd40+/+ mice (Figure 4B). These observations suggest that CD40 normally restricts the growth
of neural processes from developing MSNs by a CD40L-mediated reverse signalling mechanism.
PKC mediates both the enhancing and inhibitory effects of CD40-
activated CD40L reverse signalling on Dendrite growth
Because we have shown that activation of protein kinase C (PKC) is an essential step in the axon
growth response of developing sympathetic neurons to TNFR1-activated TNFa-mediated reverse
signaling (Kisiswa et al., 2017), we investigated whether PKC plays a role in mediating the diver-
gent effects CD40-activated CD40L reverse signalling on dendrite growth in excitatory and/or inhibi-
tory neurons. PKC is a family of at least 12 serine/threonine kinases that play key roles in several
Figure 2 continued
sCD40L, n = 51; Fc, n = 55; CD40-Fc, n = 61) and Cd40-/- (control, n = 60; sCD40L, n = 57; Fc, n = 61; CD40-Fc, n = 59). One-way ANOVA with multiple
Newman-Keuls statistical comparison with control, *p<0.01, and ***p<0.0001 (actual p values provided in the text).
DOI: https://doi.org/10.7554/eLife.30442.008
The following source data and figure supplement are available for figure 2:
Source data 1. Means, s.e.m. and n numbers for bar charts.
DOI: https://doi.org/10.7554/eLife.30442.010
Figure supplement 1. Number of primary dendrites per neuron in the neurite arbors of cultured hippocampal pyramidal neurons.
DOI: https://doi.org/10.7554/eLife.30442.009
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Figure 3. CD40-activated CD40L reverse signalling enhances axon growth from cultured hippocampal pyramidal neurons. (A) Representative
photomicrographs of neurons of Cd40+/+ and Cd40-/- E18 embryos cultured for 3 days and treated 24 hr after plating with either soluble CD40L
(sCD40L), CD40-Fc or Fc protein (each at 1 mg/ml) or untreated (control). Scale bar, 50 mm. (B) Quantification of axon length from hippocampal
pyramidal neurons of Cd40+/+ and Cd40-/- E18 embryos cultured for 3 and 9 days. Mean ± s.e.m of data collected from at least three independent
experiments at 3 days from Cd40+/+ (control, n = 74; sCD40L, n = 68; Fc, n = 72; CD40-Fc, n = 77) and Cd40-/- (control, n = 61; sCD40L, n = 64; Fc,
n = 56; CD40-Fc, n = 81); and at 9 days from Cd40+/+ (control, n = 70; sCD40L, n = 51; Fc, n = 55; CD40-Fc, n = 61) and Cd40-/- (control, n = 60;
sCD40L, n = 57; Fc, n = 61; CD40-Fc, n = 59). One-way ANOVA with multiple Newman-Keuls statistical comparisons test between the conditions
indicated, **p<0.001 and ***p<0.0001 (actual p values provided in the text).
DOI: https://doi.org/10.7554/eLife.30442.011
The following source data is available for figure 3:
Source data 1. Means, s.e.m. and n numbers for bar charts.
DOI: https://doi.org/10.7554/eLife.30442.012
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Figure 4. CD40-activated CD40L reverse signalling reduces neurite growth from cultured MSNs. (A)
Representative photomicrographs of MSNs of Cd40+/+ and Cd40-/- E14 embryos cultured for 10 days and treated
with either soluble CD40L (sCD40L) at 0.5 mg/ml, CD40-Fc or Fc protein (each at 1 mg/ml) or untreated (control).
Neurons were double labelled for bIII tubulin (red) and DARPP-32 (green) to identify MSNs. Scale bar, 50 mm. (B)
Figure 4 continued on next page
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signaling pathways that regulate a diversity of cellular functions (Mellor and Parker, 1998). In these
studies, we asked whether pharmacological manipulation of PKC activity in CD40-deficient neurons
could inhibit or mimic the effect of CD40-Fc on dendrite growth on hippocampal pyramidal neurons
and striatal MSNs cultured from Cd40-/- mice. PCK activity was inhibited by the pan-PKC inhibitor
Go6983 (Gschwendt et al., 1996) and PKC activation was mimicked by phorbol-12-myristate 13-
acetate (PMA), an analogue of diacylglycerol which participates in the activation of conventional
PKCs (PKCa, PKCb and PKCg) and novel PKCs (PKCd, PKCe, PKCq and PKCh) (Liu and Heckman,
1998).
In cultures of hippocampal pyramidal neurons established from E18 Cd40-/- mice, the significant
restoration of dendrite growth by CD40-Fc (p=3.810 4, Fc treatment compared with CD40-Fc
treatment) was completely prevented by Go6983 (p=1.610 5, CD40-Fc treatment compared with
CD40-Fc plus Go6983 treatment), although Go6983 had no effect on dendrite growth on its own
(Figure 5A and B). PMA significantly rescued the stunted dendrite phenotype of hippocampal pyra-
midal neurons established from Cd40-/- mice (p=1.610 2) almost as effectively as CD40-Fc
(Figure 5A and B). DMSO, the vehicle for Go6983 and PMA, had no significant effect on dendrite
growth (not shown). Neither Go6983 nor PMA had any significant effect on the number of pyramidal
neuron primary dendrites (not shown). These results suggest that PKC activation mediates the effect
of CD40-activated CD40L-mediated reverse signalling on dendrite growth from developing hippo-
campal pyramidal neurons.
In cultures of striatal MSNs established from E14 Cd40-/- mice, the significant suppression of den-
drite growth by CD40-Fc (p=9.310 13, Fc treatment compared with CD40-Fc treatment) was
completely inhibited by Go6983 (p=2.510 7, CD40-Fc treatment compared with CD40-Fc plus
Go6983 treatment) and as in hippocampal neuron cultures, Go6983 had no effect on MSN dendrite
growth on its own (Figure 5C and D). PMA significantly suppressed dendrite growth from MSNs
(p=4.510 17) to the same extent as CD40-Fc. Neither Go6983 nor PMA had any significant effect
on the number of MSN primary dendrites (not shown). These results suggest that PKC activation
mediates the effect of CD40-activated CD40L on dendrite growth suppression from developing
MSNs.
PKC-b and PKC-g mediate the opposite effects of CD40-activated
CD40L reverse signalling on hippocampal and striatal neurons,
respectively
To investigate whether particular PKC isoforms selectively participate in mediating the effects of
CD40-activated CD40L reverse signalling on dendrite growth, we studied the effects of siRNA knock
down of selected PKC isoforms. Because PMA strongly activates conventional and novel PKC iso-
forms (Wu-Zhang and Newton, 2013), we first checked expression of the conventional and novel
PKC isoforms that have been reported to be abundantly expressed in whole brain. Using western
blotting, we showed abundant expression of PKC-a, b, g and e in both the hippocampus and stria-
tum (Figure 6—figure supplement 1). We subsequently transfected cultures of hippocampal and
striatal neurons with siRNA oligonucleotides directed to each of these isoforms and with a control
RNA that has a scrambled sequence, and used western blotting to ascertain whether knockdown
was successful. Because we were able to consistently and efficiently knock down PKC-b and PKC-g
expression with specific siRNA in these cultures (Figure 6—figure supplement 1), we focused sub-
sequent experiments on these isoforms.
Figure 4 continued
Quantification of total neurite lengths of MSNs after 10 days in vitro. Mean ± s.e.m of data collected from three
independent experiments from Cd40+/+ (control, n = 69; sCD40L, n = 65; Fc, n = 63; CD40-Fc, n = 62) and Cd40-/-
(control, n = 60; sCD40L, n = 62; Fc, n = 52; CD40-Fc, n = 73). One-way ANOVA with multiple Newman-Keuls
statistical comparisons with control. ***p<0.0001 (actual p values provided in the text).
DOI: https://doi.org/10.7554/eLife.30442.013
The following source data is available for figure 4:
Source data 1. Means, s.e.m. and n numbers for bar charts.
DOI: https://doi.org/10.7554/eLife.30442.014
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Figure 5. PKC mediates the effect of CD40-activated CD40L reverse signalling on dendrite growth. (A) Representative photomicrographs of
hippocampal neurons of Cd40-/- E18 embryos cultured for 9 days and treated 24 hr after plating with either 1 mg/ml CD40-Fc, 1 mg/ml Fc protein, 500
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Initial siRNA experiments were carried out on neurons cultured from Cd40+/+ mice. Compared
with dendrite growth from hippocampal pyramidal neurons transfected with control siRNA, dendrite
growth was significantly decreased by PKC-b siRNA (p=4.910 3) but not by PKC-g siRNA
(Figure 6A and B). Conversely, PKC-g siRNA but not PKC-b siRNA significantly increased dendrite
growth from MSNs compared with control siRNA (p=1.610 4) (Figure 6C and D). This suggests
that PKC-b and PKC-g participate in regulating dendrite growth from developing hippocampal pyra-
midal neurons and MSNs, respectively.
We subsequently tested whether these siRNAs selectively inhibited the rescue of the dendrite
growth phenotype of neurons cultured Cd40-/- mice by CD40-Fc. Whereas CD40-Fc rescued the
impaired dendrite growth of CD40-deficient hippocampal pyramidal neurons transfected with con-
trol siRNA, PKC-b siRNA completely prevented CD40-Fc rescue (p=5.710 8) (Figure 6A and B).
Whereas CD40-Fc reduced the exuberant dendrite growth of CD40-deficient MSNs transfected with
control siRNA, PKC-g siRNA significantly impaired this effect of CD40-Fc (p=7.410 4) (Figure 6C
and D). Taken together, these results implicate PKC-b and PKC-g in mediating the effects of CD40L
reverse signaling in hippocampal pyramidal neurons and MSNs, respectively.
Expression of CD40 and CD40L
The striking and opposite effects of CD40-activated CD40L-mediated reverse signalling on the
growth and elaboration of the dendritic arbors of excitatory hippocampal pyramidal neurons and
inhibitory striatal MSNs raised the question of the cellular source of CD40 and how it activates
CD40L in vivo. To address this question, we used western blotting and immunochemistry to ascer-
tain the timing of CD40 and CD40L expression in the hippocampus and striatum. Western blotting
revealed that both CD40 and CD40L are expressed in the hippocampus and striatum throughout
development and in the adult, with highest levels of both proteins postnatally (Figure 7—figure sup-
plement 1). CD40 immunoreactivity was lost in tissue obtained from Cd40-/- mice (Figure 7—figure
supplement 1A), confirming antibody specificity. Immunohistochemisty revealed that CD40 and
CD40L are widely expressed in the hippocampus (Figure 7) and striatum (Figure 8). Double labelling
with anti-MAP2, which labels dendrites, showed that CD40 and CD40L are expressed throughout
the dendrite fields of pyramidal and striatal neurons and double labelling with anti-GFAP, which
labels astrocytes, showed that CD40 and CD40L are also expressed by these cells. CD40 immunore-
activity was not observed in hippocampal and striatal sections of Cd40-/- mice and no labelling was
observed when the primary antibody was omitted (Figures 7 and 8). Double labelling for CD40 and
CD40L in dissociated hippocampal and striatal cultures suggest that the great majority of pyramidal
neurons and MSNs co-express CD40 and CD40L (Figure 9).
Discussion
We have discovered that CD40 is a major novel regulator of dendrite arborisation in the developing
brain that exerts prominent disparate effects on major populations of excitatory and inhibitory neu-
rons. Analysis of Golgi preparations of CD40-deficient postnatal mice revealed that the apical and
basal dendrite arbors of excitatory hippocampal pyramidal neurons were very much smaller and less
Figure 5 continued
n = 34; Fc, n = 33; CD40-Fc, n = 37; CD40-Fc + Go6983, n = 37; PMA, n = 34). (C). Representative photomicrographs of MSNs of Cd40-/- E14 embryos
cultured for 10 days and treated as indicated. MSNs were identified by double labelling for bIII tubulin (red) and DARPP-32 (green). Scale bar, 50 mm.
(D) Quantification of total neurite lengths of MSNs after 10 days in vitro. Mean ± s.e.m of data collected from three independent experiments in Cd40-/-
(control, n = 56; DMSO, n = 46; Go6983, n = 49; Fc, n = 50; CD40-Fc, n = 61; CD40-Fc + Go6983, n = 48; PMA, n = 58). *p<0.01 and ***p<0.0001,
statistical comparison with the equivalent control (Fc for CD40-Fc and DMSO for PMA, actual p values provided in the text), one-way ANOVA with
multiple Newman-Keuls tests.
DOI: https://doi.org/10.7554/eLife.30442.015
The following source data is available for figure 5:
Source data 1. Means, s.e.m. and n numbers for pyramidal neuron bar charts.
DOI: https://doi.org/10.7554/eLife.30442.016
Source data 2. Means, s.e.m. and n numbers for medium spiny neuron bar charts.
DOI: https://doi.org/10.7554/eLife.30442.017
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Figure 6. PKC-b and PKC-g selectively participate in mediating the effects of CD40-activated CD40L reverse signalling on dendritic growth. (A)
Representative photomicrographs of hippocampal neurons of Cd40+/+ and Cd40-/- E18 embryos transfected with either control siRNA or PKC-b siRNA
and cultured for 9 days. The Cd40-/- neurons were treated with either 1 mg/ml Fc protein or 1 mg/ml CD40-Fc. Scale bar, 100 mm. (B) Quantification of
dendrite length from hippocampal pyramidal neurons of Cd40+/+ and Cd40-/- E18 embryos cultured for 9 days. Mean ± s.e.m of data collected from
Figure 6 continued on next page
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branched than those of wild type littermates whereas the dendrite arbors of inhibitory striatal
medium spiny neurons were greatly increased in size and more branched in the absence of CD40.
These pronounced and opposite in vivo phenotypic changes were replicated in excitatory and inhibi-
tory neurons cultured from Cd40-/- mice. In both cases, these distinctive in vitro phenotypes were
completely rescued in neurons cultured from Cd40-/- mice by soluble CD40 (CD40-Fc), and were
mimicked in neurons cultured from Cd40+/+ mice by soluble CD40L treatment. These observations
together with our demonstration that both hippocampal excitatory and striatal inhibitory neurons
display CD40L immunoreactivity, suggests that CD40 exerts its distinctive effects on dendrite arbor-
isation in both excitatory and inhibitory neurons by a reverse signalling mechanism.
Our demonstration that both hippocampal excitatory pyramidal neurons and striatal inhibitory
medium spiny neurons co-express CD40L and CD40 raise the possibility that CD40 activates CD40L
in both kinds of neurons by an autocrine mechanism. We have previously reported that CD40-acti-
vated CD40L reverse signaling enhances axon growth from developing sympathetic neurons in vitro
and contributes to the establishment of the sympathetic innervation of a specific subset of tissues in
vivo (McWilliams et al., 2015). Because sympathetic neurons co-express CD40 and CD40L and can
be cultured at exceptionally low density, it was possible to demonstrate that CD40-activates CD40L
in sympathetic neurons by an autocrine mechanism. Because pyramidal neurons and MSNs have to
be grown at much higher density and because these cultures contain a variety of cell types, including
glial cells, it has not been possible to exclude the possibility that CD40L is also activated by para-
crine mechanism in CNS neurons. Our demonstration that GFAP-positive astrocytes express CD40
and reports that microglia express low levels of CD40 (Carson et al., 1998; Nguyen et al., 1998)
raise the possibility that CNS glia may play a role in activating CD40L in neurons. However, since
CD40L and CD40 play a central role in immune responses (Peters et al., 2009), it is possible that
microglial CD40 is related primarily to immune function, especially as CD40 is upregulated in these
cells by proinflammatory cytokines (Carson et al., 1998; Nguyen et al., 1998).
A growing body of evidence has implicated several members of the TNFSF in the regulation of
axon growth and tissue innervation in developing PNS by either forward or reverse signalling mecha-
nisms. Typically, individual TNFSF members act on restricted populations of PNS neurons and either
promote axon growth or inhibit axon growth-promoting effects of neurotrophins (Desbarats et al.,
2003; Gavalda` et al., 2009,2013; Kisiswa et al., 2013, 2017; McWilliams et al., 2015;
O’Keeffe et al., 2008; Wheeler et al., 2014). Here we not only demonstrate marked physiologically
Figure 6 continued
four separate experiments of Cd40+/+ neurons (control siRNA transfected, n = 32; PKC-b siRNA transfected, n = 33; PKC-g siRNA transfected, n = 27)
and Cd40-/- neurons (control siRNA transfected, Fc treated, n = 39; control siRNA transfected, CD40-Fc treated, n = 35; PKC-b siRNA transfected, Fc
treated, n = 39; PKC-b siRNA transfected, CD40-Fc treated, n = 39). (C) Representative photomicrographs of MSNs of Cd40+/+ and Cd40-/- E14
embryos transfected with either control siRNA or PKC-g siRNA and cultured for 10 days. The Cd40-/- neurons were treated with either 1 mg/ml Fc
protein or 1 mg/ml CD40-Fc. MSNs were identified by DARPP-32 (red) and transfected neurons by the expression of GFP (green). * indicates transfected
neurons that were not positive for DARPP-32. Scale bar, 50 mm. (D) Quantification of neurite length from MSNs of Cd40+/+ and Cd40-/- E14 embryos
cultured for 10 days. Mean ± s.e.m of data collected from four separate experiments of Cd40+/+ neurons (control siRNA transfected, n = 27; PKC-b
siRNA transfected, n = 26; PKC-g siRNA transfected, n = 25) and Cd40-/- neurons (control siRNA transfected, Fc treated, n = 34; control siRNA
transfected, CD40-Fc treated, n = 26; PKC-g siRNA transfected, Fc treated, n = 29; PKC-g siRNA transfected, CD40-Fc treated, n = 24). **p<0.01 and
***p<0.001, actual p values provided in the text, one-way ANOVA with multiple Newman-Keuls tests.
DOI: https://doi.org/10.7554/eLife.30442.018
The following source data and figure supplement are available for figure 6:
Source data 1. Means, s.e.m. and n numbers for Cd40+/+ pyramidal neuron bar charts.
DOI: https://doi.org/10.7554/eLife.30442.020
Source data 2. Means, s.e.m. and n numbers for Cd40+/+ medium spiny neuron bar charts.
DOI: https://doi.org/10.7554/eLife.30442.021
Source data 3. Means, s.e.m. and n numbers for Cd40-/- pyramidal neuron bar charts.
DOI: https://doi.org/10.7554/eLife.30442.022
Source data 4. Means, s.e.m. and n numbers for Cd40-/- medium spiny neuron bar charts.
DOI: https://doi.org/10.7554/eLife.30442.023
Figure supplement 1. Expression of PKC isoforms in the hippocampus and striatum and siRNA knockdown of PKC-b and PKC-g hippocampal and
striatal cultures.
DOI: https://doi.org/10.7554/eLife.30442.019
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Figure 7. Localization of CD40 and CD40L in the developing hippocampus. Representative images of sections of the CA1 region of P9 hippocampi
labelled with either anti-CD40 (A) or anti-CD40L (B) together with DAPI and either anti-MAP-2 or anti-GFAP (pl, pyramidal layer; sr, stratum radiatum;
slm, stratum lacunosum moleculare). (C) Antibody specificity controls: sections of the hippocampus of P9 Cd40-/- mice incubated with the anti-CD40
antibody and sections of the hippocampus of P9 Cd40+/+ mice that received no primary antibody. Scales bar, 50 mm.
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relevant effects of CD40L reverse signalling on dendrite growth and branching in functionally differ-
ent kinds of CNS neurons but show that CD40-activated CD40L reverse signalling can either pro-
mote or inhibit dendritic arborisation in different kinds of neurons. Our work reveals that a particular
TNFSF member exerts distinctive, neuron-specific effects on CNS dendrite growth. In addition to
the hippocampal and striatal neurons studied here, it is clear that CD40 and CD40L are widely
expressed in the developing brain neurons (not shown). Thus, it is possible that CD40 has more
widespread effects on the growth of neural processes in the developing brain than those docu-
mented here.
In addition to our demonstration that CD40 is physiologically relevant regulator of dendrite
growth in the developing brain in vivo, we showed that CD40-activated CD40L-mediated reverse
signalling promotes hippocampal pyramidal axon growth in vitro. This raises the possibility that
CD40-activated CD40L-mediated reverse signalling may be a physiologically important regulator of
pyramidal neuron axon growth in vivo. However, because the full extent of hippocampal pyramidal
axons cannot be reliably discerned in Golgi preparations, we were not able to establish whether
CD40L reverse signalling is physiological relevant for pyramidal axon growth in vivo. We have
reported that the TNFSF member APRIL enhances the axon growth, but not dendrite growth, from
cultured hippocampal pyramidal neurons (Oso´rio et al., 2014), although the physiological relevance
of this observation is unclear. However, we have recently shown that APRIL enhances axon growth
from cultured midbrain dopaminergic neurons and that the initial nigrostriatal projection is signifi-
cantly compromised in April-/- embryos (McWilliams et al., 2017)
It has been reported that CD40 expression is retained in the adult brain, with most of the neurons
of the dentate gyrus, hippocampal pyramidal layer and 60% of neurons in cerebral neocortex retain-
ing expression (Tan et al., 2002). There is also some evidence for a neurodegenerative phenotype in
aged CD40-deficient mice, with TUNEL-positive cells in the dentate gyrus, hippocampal pyramidal
cell layer and neocortex and decreased level of neurofilament isoforms in whole brain lysates
(Tan et al., 2002). Although the reason for these late degenerative changes is unclear, it is possible
that the marked reduction in the size and complexity of pyramidal neuron dendritic arbors that we
have documented in the postnatal and adult brain may contribute by impairing trophic maintenance
of the degenerating neurons.
Our demonstration that pharmacological inhibition of PKC completely prevented the rescue of
the distinctive dendrite phenotypes of CD40-deficient hippocampal and striatal neurons by soluble
CD40-Fc and that pharmacological activation of PKC was as effective as CD40-Fc in rescuing these
phenotypes suggests that PKC activation is an essential step in the effect of CD40-activated CD40L
reverse signalling on dendrite growth in both kinds of neurons. This finding extends the importance
of PKC in mediating the axon growth response of developing sympathetic neurons to TNFR1-acti-
vated TNF reverse signaling (Kisiswa et al., 2017) to another example of TNFSF reverse signaling
affecting neural process growth. Moreover, it shows that PKC activation mediates both the growth-
promoting and growth-inhibitory effects of reverse signaling in different kinds of neurons. PKC inhi-
bition also prevents enhanced neurite growth from cultured embryonic hippocampal neurons by
neuregulin-1 (Gerecke et al., 2004), whereas PKC activation increases dendrite growth and branch-
ing from these neurons by modulating neurotrophin synthesis (Lim and Alkon, 2012).
Using specific siRNA to knockdown the expression of different PKC isoforms, we have implicated
the selective participation of PKC-b and PKC-g in mediating the opposite effects of CD40L reverse
signaling on dendrite growth from hippocampal pyramidal neurons and MSNs, respectively. While
our findings do to exclude the participation of additional PKC isoforms in the signaling networks
leading to increases or decreases in dendrite growth and branching, it will be intriguing in future
work to ascertain how PKC-b and PKC-g play these distinctive roles in neurons.
Figure 7 continued
DOI: https://doi.org/10.7554/eLife.30442.024
The following figure supplement is available for figure 7:
Figure supplement 1. Expression of CD40 and CD40L in the developing hippocampus and striatum.
DOI: https://doi.org/10.7554/eLife.30442.025
Carriba and Davies. eLife 2017;6:e30442. DOI: https://doi.org/10.7554/eLife.30442 15 of 22
Research article Neuroscience
AB C
D
hip
st cc
ctx
st
cc
ctx
no primary antibody DAPI merge
CD40 DAPI merge
Cd40
-/-
Cd40
+/+
hip
st
cc
st
ctx
ctx
cc
st
ctx
cc
st
ctx
cc
st
ctx
cc
MAP-2
CD40
GFAP MAP-2 GFAP
CD40L
DAPI DAPI DAPI DAPI
merge merge merge merge
CD40 CD40L
DARPP-32 DAPI merge
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Our current study extends the role of CD40L reverse signalling from modulating the growth of a
subset of sympathetic axons in the PNS to that of a major, physiologically relevant regulator of den-
drite growth and elaboration in the developing CNS, having distinctive and opposite effects on
Figure 8 continued
incubated with the anti-CD40 antibody and sections of the striatum of P9 Cd40+/+ mice that received no primary antibody (st, striatum; hip,
hippocampus; ctx, cortex; cc, corpus callosum). Scale bar, 50 mm.
DOI: https://doi.org/10.7554/eLife.30442.026
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Figure 9. Co-localization of CD40 and CD40L in the cultured hippocampal pyramidal neurons and striatal MSNs. (A) Representative images of
dissociated E18 hippocampal cultures after 9 days in vitro triple labelling with anti-CD40, anti-CD40L and DAPI. The upper panels show images of
neuronal cell bodies and proximal neural processes. The lower panels show distal neural processes. (B) Representative images of dissociated E14
striatal cultures after 10 days in vitro triple labelling with anti-CD40, anti-CD40L and bIII tubulin. Scale bar, 20 mm.
DOI: https://doi.org/10.7554/eLife.30442.027
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excitatory and inhibitory neurons. This work raises a host of important questions for future work,
including how extensively CD40L reverse signalling regulates neuronal morphology and the func-
tional properties of neural circuits, what are behavioural consequences of the major cellular pheno-
types observed in CD40-deficient mice, its role in neural plasticity in the adult and what its
contribution to the neurological sequelae of CNS inflammatory conditions might be.
Materials and methods
Mice
Mice were housed in a 12 hr light-dark cycle with access to food and water ad libitum. Breeding was
approved by the Cardiff University Ethical Review Board and was performed within the guidelines of
the Home Office Animals (Scientific Procedures) Act, 1986. Cd40 null mutant mice in a C57BL6/J
background were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA). These mice
were back-crossed for at least 10 generations into a CD1 background before undertaking any of the
current experimental work. Cd40+/- mice were crossed to generate Cd40+/+ and Cd40-/- littermates.
Neuron culture
Primary hippocampal neuron cultures were prepared as described previously (Kaech and Banker,
2006), with modifications. Briefly, hippocampi were dissected from embryonic day 18 (E18) mouse
fetuses and were triturated to produce a single cell suspension following trypsin digestion (Wor-
thington, Lakewood, NJ, USA) and DNase I treatment (Roche Applied Science, UK). The neurons
were plated in of 35 mm plastic dishes coated with poly-L-lysine (Sigma-Aldrich, UK) at a density of
15,000 cells/cm2 and were cultured in Neurobasal A (Invitrogen, UK) supplemented with 2% B27
(Invitrogen, UK), 0.5 mM GlutaMAX I (Invitrogen, UK), 100 units/ml penicillin and 100 mg/ml strepto-
mycin (Gibco BRL, UK).
Medium spiny neuron (MSN) cultures were prepared from E14 striatal primordia that were tritu-
rated to produce a single cell suspension following trypsin digestion (Worthington, Lakewood,
NJ, USA) and DNase I treatment (Roche Applied Science, UK). Neurons were plated at a density of
15,000 cells/cm2 at the center of 35 mm dishes coated with poly-L-lysine (Sigma-Aldrich, UK). Cells
were cultured with Neurobasal A (Invitrogen, UK) supplemented with 2% B27 (Invitrogen, UK), 1%
Foetal Calf Serum (FCS) (Sigma-Aldrich, UK), 100 units/ml penicillin and 100 mg/ml streptomycin
(Gibco BRL, UK). To avoid extensive astrocyte proliferation, the medium was changed to medium
without FCS after 7 days in vitro.
Hippocampal and striatal cultures were incubated at 37˚C in a humidified atmosphere containing
5% CO2 and in both cases were treated the day after plating. The culture medium was partially
replaced with fresh medium with the treatments every 4–5 days. The cultures were treated with the
following reagents as indicated in the text: soluble CD40L (sCD40L) (Enzo Life Sciences, Farming-
dale, NY, USA, ALX-522–120 C010), CD40-Fc (Enzo Life Sciences, ALX-522–016 C050), Fc protein
(Enzo Life Sciences, ALX-203–004 C050), Go6983 (Tocris Biosciences, UK, cat. no. 2285) and phor-
bol-12-myristate-13-acetate (PMA) (MERCK, UK, cat. no. 524400). Go6983 and PMA were reconsti-
tuted in DMSO and diluted in culture medium to the concentration indicated. Control cultures
received an equivalent amount of DMSO. For PKC experiments, the cells were plated in 24 well
dishes.
Analysis of dendrite morphology
In hippocampal cultures, the neurite arbors of a proportion of the neurons were visualised in 3 day
cultures by the fluorescent vital dye calcein-AM added at the end of the experiment and in 9 days
cultures by transfecting the neurons with a GFP expression plasmid after 7 days in vitro using lipo-
fectamine 2000 (Invitrogen, UK) according to the manufacturer’s instructions with modifications.
Briefly, the cultures were treated for 3 hr with a mixture of the expression vector and lipofectamine,
after which they were washed with medium and cultured for a further 48 hr. The neurons were fixed
for 30 min with 4% paraformaldehyde. MSN cultures were fixed with 4% paraformaldehyde after 10
days in vitro, after which they were permeabilizated with 0.1% Triton-X100 and blocked with 0.5%
BSA before labeling with anti-DARPP-32 (1:400 Cell Signaling Technology, Danvers, MA, USA) to
identify MSNs. Analysis of neuronal morphology was studied after double labeling with anti-bIII
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tubulin (1:1500; chicken ab41489, AbCam, UK). After washing, the cultures were incubated with the
appropriate fluorescent Alexa secondary antibodies (1:500; Thermofisher, UK, A-21206 and
A-11042).
For the experiments of siRNA, 48 hr before fixing the neurons for the analysis of dendrite mor-
phology, the neurons were co-transfected using lipofectamine with a GFP expression plasmid
together with either of the following Silencer Select siRNA oligonucleotides at 10 nM: Silencer select
negative control n.1, Prkcb mouse and Prkcg mouse (catalogue numbers 4390843, s71692 and
s71693, respectively, Thermofisher, UK). For siRNA experiments on Cd40-/- neurons, the neurons
were treated with either Fc or CD40-Fc after transfection.
Labelled neurons were visualized using a Zeiss LSM710 confocal microscope. Neurite arbors were
assessed using Fiji (ImageJ) software with the semi-automated plugin Simple Neurite Tracer
(Longair et al., 2011). All neurons labeled were counted without any criterion of exclusion. The
mean and standard errors of the measurements from at least three independent experiments are
plotted.
Golgi preparations
Modified Golgi-Cox impregnation was performed on 150 mm coronal sections for the hippocampus
and 100 mm parasagittal sections for the striatum of P10, P30 and adult mouse brains of Cd40+/+
and Cd40-/- littermates using the FD Rapid GolgiStain kit (FD NeuroTechnologies, Ellicott City, MD,
USA). Sholl analysis was carried out separately on the apical and basal dendritic arbors of pyramidal
neurons in the CA1 hippocampal field and on the dendrite arbors of MSNs using the plugin Sholl
Analysis of the Fiji software (Schindelin et al., 2012) after neuronal reconstruction with the plugin
Simple Neurite Tracer (Longair et al., 2011).
Immunoblotting
Hippocampal and striatal tissue was placed in triton lysis buffer supplemented with protease and
phosphatase inhibitor cocktail mix (Sigma-Aldrich, UK). Cultured neurons were first washed with ice-
cold PBS and lysed with triton lysis buffer supplemented with protease and phosphatase inhibitor
cocktail mix. For experiments to confirm siRNA knock down, the neurons were grown at very high
density in 60 mm tissue culture dishes.
Insoluble debris was removed by centrifugation at 14,000 g for 10 min at 4˚C. Equal quantities of
protein were run on SDS-PAGE gels, and were transferred to PVDF membranes (Immobilon-P, Milli-
pore, UK) that were incubated with blocking solution (5% non-fat dry milk in TBS with 0.1% tween-
20, TBS-T). After washing with TBS-T the blots were probed with the following antibodies: anti-
CD40 (1:450; rat MAB4401, R and D, UK), anti-CD40L (1:700; rabbit ab2391, AbCam, UK), anti-
PKC-a (1:1000, mouse 610107, BD Transduction Laboratories, UK), anti-PKC-b (1:250, mouse
610127, BD Transduction Laboratories, UK), anti-PKC-g (1:1000; rabbit 43806S, Cell Signaling Tech-
nology, Danvers, MA, USA), anti-PKC-e (1:1000, mouse 610085, BD Transduction Laboratories, UK),
anti-GAPDH (1:90,000; mouse G8795, Sigma, UK) or anti-actin (1;60,000: mouse ab3280, AbCam,
UK). Bound primary antibodies were visualized with HRP-conjugated goat anti-rat (1:1000, 7077, Cell
Signaling Technology, Danvers, MA, USA), donkey anti-rabbit or anti-mouse secondary antibodies
(1:5000; rabbit W4011, mouse W4021, Promega, UK) and EZ-ECL kit Enhanced Chemiluminescence
Detection Kit (Biological Industries, Geneflow Limited, UK).
Immunohistochemistry and immunocytochemistry
For immunohistochemistry, P9 brains were fixed in fresh 4% paraformaldehyde in 0.12 M phosphate
buffer, pH 7.2 for 24 hr at 4˚C. After washing in PBS, the tissue was cryoprotected in 30% sucrose
before being frozen. Tissue was frozen in isopentene cooled with dry ice and was serially sectioned
at 30 mm. After washing with PBS, the sections were permeabilizated with 0.1% Triton X-100 (Sigma-
Aldrich, UK) for 1 hr and then blocked with 1% BSA and 0.1% Triton X-100 (Sigma-Aldrich, UK) in
PBS for 2 hr at room temperature. Primary antibodies were prepared in PBS with 0.5% BSA and
0.1% Triton X-100, and incubated overnight at 4˚C. Primary antibodies were: rabbit polyclonal anti-
CD40L (1:150, AbCam, UK, catalogue number ab2391), rat monoclonal anti-CD40 (1:100, AbCam,
UK, catalogue number ab22469), chicken anti-MAP2 (1:5000, AbCam, UK, catalogue number
ab5392), chicken anti-GFAP (1:2000, AbCam, UK, catalogue number ab4674), rabbit monoclonal
Carriba and Davies. eLife 2017;6:e30442. DOI: https://doi.org/10.7554/eLife.30442 19 of 22
Research article Neuroscience
anti-DARPP-32 (1:400 Cell Signaling Technology, Danvers, MA, USA, catalogue number 2306) and
chicken anti-bIII tubulin (1:1500, AbCam, UK, catalogue number ab41489). The sections were
washed in PBS and were incubated for 1 hr with secondary fluorescent Alexa antibodies (1:500; Ther-
mofisher, UK, A-21207; A-11006; A-11042; A-11039; AbCam, ab175674). Negative controls (no pri-
mary antibody and staining of tissues from Cd40-/- mice) were also set up. After washing with PBS,
the sections were mounted on slices with Fluoromount-G (Cambridge Bioscience, UK). Images were
obtained with Zeiss LSM710 confocal microscope.
For immunocytochemistry, cultures were fixed as above for 15 min at room temperature and
were washed extensively with PBS before permeabilization and blocking of nonspecific binding for 1
hr at room temperature as above. The cultures were incubated overnight at 4˚C with rabbit poly-
clonal anti-CD40L (1/200), rat monoclonal anti-CD40 (1/200) and for the striatal cultures also with
anti-bIII tubulin (1/1500). After washing with PBS, the cultures were incubated with donkey anti-rab-
bit Alexa 594, goat anti-rat Alexa 488 and goat anti-chicken Alexa 405 (1:500, Thermofisher, UK;
A-21207; A-11006; AbCam, ab175674). Images were obtained using a Zeiss LSM710 confocal
microscope.
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